A citation-based method for searching scientific literature

Richard G Moore, Amy K Brown, M Craig Miller, Steven Skates, W Jeffrey Allard, Thorsten Verch, Margaret Steinhoff, Geralyn Messerlian, Paul DiSilvestro, C O Granai, Robert C Bast. Gynecol Oncol 2008
Times Cited: 434







List of co-cited articles
738 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
Richard G Moore, D Scott McMeekin, Amy K Brown, Paul DiSilvestro, M Craig Miller, W Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C Bast, Steven J Skates. Gynecol Oncol 2009
491
49

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter, Jeffrey A Ledbetter, Michèl Schummer, Martin McIntosh, Charles Drescher, Nicole Urban, Karl Erik Hellström. Cancer Res 2003
477
29

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.
Richard G Moore, M Craig Miller, Paul Disilvestro, Lisa M Landrum, Walter Gajewski, John J Ball, Steven J Skates. Obstet Gynecol 2011
158
25


Comprehensive analysis of HE4 expression in normal and malignant human tissues.
Mary T Galgano, Garret M Hampton, Henry F Frierson. Mod Pathol 2006
272
23

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
Ronny Drapkin, Hans Henning von Horsten, Yafang Lin, Samuel C Mok, Christopher P Crum, William R Welch, Jonathan L Hecht. Cancer Res 2005
360
21

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.
Richard G Moore, Moune Jabre-Raughley, Amy K Brown, Katina M Robison, M Craig Miller, W Jeffery Allard, Robert J Kurman, Robert C Bast, Steven J Skates. Am J Obstet Gynecol 2010
169
19

Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis.
Jiwen Wang, Jia Gao, Hongwen Yao, Zongyong Wu, Minjie Wang, Jun Qi. Tumour Biol 2014
64
28

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.
T Van Gorp, I Cadron, E Despierre, A Daemen, K Leunen, F Amant, D Timmerman, B De Moor, I Vergote. Br J Cancer 2011
203
17

HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.
Cesare Romagnolo, Antonette E Leon, Aline S C Fabricio, Martina Taborelli, Jerry Polesel, Lino Del Pup, Agostino Steffan, Silvia Cervo, Antonella Ravaggi, Laura Zanotti,[...]. Gynecol Oncol 2016
57
24

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
Fake Li, Ruxiu Tie, Kai Chang, Feng Wang, Shaoli Deng, Weiping Lu, Lili Yu, Ming Chen. BMC Cancer 2012
73
19

Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.
E M J Meys, J Kaijser, R F P M Kruitwagen, B F M Slangen, B Van Calster, B Aertgeerts, J Y Verbakel, D Timmerman, T Van Gorp. Eur J Cancer 2016
90
15

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
517
13

Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
Jose M Escudero, Jose M Auge, Xavier Filella, Aureli Torne, Jaume Pahisa, Rafael Molina. Clin Chem 2011
136
13

Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age.
Richard G Moore, Michael Craig Miller, Elizabeth E Eklund, Karen H Lu, Robert C Bast, Geralyn Lambert-Messerlian. Am J Obstet Gynecol 2012
95
13

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.
Brian Nolen, Liudmila Velikokhatnaya, Adele Marrangoni, Koen De Geest, Aleksey Lomakin, Robert C Bast, Anna Lokshin. Gynecol Oncol 2010
110
13

Reactivity of a monoclonal antibody with human ovarian carcinoma.
R C Bast, M Feeney, H Lazarus, L M Nadler, R B Colvin, R C Knapp. J Clin Invest 1981
12

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.
M Schummer, W V Ng, R E Bumgarner, P S Nelson, B Schummer, D W Bednarski, L Hassell, R L Baldwin, B Y Karlan, L Hood. Gene 1999
259
12

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Mona A Karlsen, Estrid V S Høgdall, Ib J Christensen, Christer Borgfeldt, Grigorios Kalapotharakos, Lenka Zdrazilova-Dubska, Josef Chovanec, Christianne A R Lok, Anna Stiekema, Irene Mutz-Dehbalaie,[...]. Gynecol Oncol 2015
51
23

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.
Toon Van Gorp, Joan Veldman, Ben Van Calster, Isabelle Cadron, Karin Leunen, Frederic Amant, Dirk Timmerman, Ignace Vergote. Eur J Cancer 2012
76
15

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Mona Aarenstrup Karlsen, Noreen Sandhu, Claus Høgdall, Ib Jarle Christensen, Lotte Nedergaard, Lene Lundvall, Svend A Engelholm, Anette T Pedersen, Dorthe Hartwell, Magnus Lydolph,[...]. Gynecol Oncol 2012
138
12

Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome.
M T Sandri, F Bottari, D Franchi, S Boveri, M Candiani, S Ronzoni, M Peiretti, D Radice, R Passerini, M Sideri. Gynecol Oncol 2013
66
18

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases.
Rafael Molina, Jose M Escudero, Jose M Augé, Xavier Filella, Laura Foj, Aureli Torné, Jose Lejarcegui, Jaume Pahisa. Tumour Biol 2011
104
12

Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review.
Simona Ferraro, Federica Braga, Monica Lanzoni, Patrizia Boracchi, Elia Mario Biganzoli, Mauro Panteghini. J Clin Pathol 2013
110
12

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
750
11


Human epididymis protein 4 reference limits and natural variation in a Nordic reference population.
Nils Bolstad, Miriam Øijordsbakken, Kjell Nustad, Johan Bjerner. Tumour Biol 2012
73
15

The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
Martina Montagnana, Elisa Danese, Orazio Ruzzenente, Valentina Bresciani, Teresita Nuzzo, Matteo Gelati, Gian Luca Salvagno, Massimo Franchi, Giuseppe Lippi, Gian Cesare Guidi. Clin Chem Lab Med 2011
125
11

Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
Xinliang Chen, Hui Zhou, Rui Chen, Jian He, Ying Wang, Lisi Huang, Longqiaozi Sun, Chaohui Duan, Xiaohong Luo, Haiyan Yan. Clin Chim Acta 2015
25
44

Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
Robert L Coleman, Thomas J Herzog, Daniel W Chan, Donald G Munroe, Todd C Pappas, Alan Smith, Zhen Zhang, Judith Wolf. Am J Obstet Gynecol 2016
55
20

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11


Elevated human epididymis protein 4 concentrations in chronic kidney disease.
Béla Nagy, Zoárd T Krasznai, Heidi Balla, Mária Csobán, Péter Antal-Szalmás, Zoltán Hernádi, János Kappelmayer. Ann Clin Biochem 2012
75
13

Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.
Katarzyna M Terlikowska, Bozena Dobrzycka, Anna M Witkowska, Beata Mackowiak-Matejczyk, Tomasz Kamil Sledziewski, Maciej Kinalski, Slawomir J Terlikowski. J Ovarian Res 2016
26
38

Modification of cut-off values for HE4, CA125 and the ROMA algorithm for early-stage epithelial ovarian cancer detection: Results from 1021 cases in South China.
Ying Xu, Rihui Zhong, Jian He, Rui Ding, Haixiong Lin, Yawen Deng, Lijun Zhou, Xiaohui Li, Junyi Jiang, Yunwen Bao,[...]. Clin Biochem 2016
22
45


Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response.
Elham O Hamed, Hydi Ahmed, Osama B Sedeek, Abeer M Mohammed, Ali A Abd-Alla, Hazem M Abdel Ghaffar. Diagn Pathol 2013
55
18



No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting.
Francis Jacob, Mara Meier, Rosmarie Caduff, Darlene Goldstein, Tatiana Pochechueva, Neville Hacker, Daniel Fink, Viola Heinzelmann-Schwarz. Gynecol Oncol 2011
120
10

Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders.
Richard G Moore, Michael Craig Miller, Margaret M Steinhoff, Steven J Skates, Karen H Lu, Geralyn Lambert-Messerlian, Robert C Bast. Am J Obstet Gynecol 2012
85
11

Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review.
Vincent Dochez, Hélène Caillon, Edouard Vaucel, Jérôme Dimet, Norbert Winer, Guillaume Ducarme. J Ovarian Res 2019
118
10

Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass.
Khawla Al Musalhi, Manal Al Kindi, Faiza Al Aisary, Fatma Ramadhan, Thuraya Al Rawahi, Khalsa Al Hatali, Waad-Allah Mula-Abed. Oman Med J 2016
19
47

Simple ultrasound-based rules for the diagnosis of ovarian cancer.
D Timmerman, A C Testa, T Bourne, L Ameye, D Jurkovic, C Van Holsbeke, D Paladini, B Van Calster, I Vergote, S Van Huffel,[...]. Ultrasound Obstet Gynecol 2008
262
9

Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings.
Sarikapan Wilailak, Karen K L Chan, Chi An Chen, Joo Hyun Nam, Kazunori Ochiai, Tar Choon Aw, Subathra Sabaratnam, Sudarshan Hebbar, Jaganathan Sickan, Beth A Schodin,[...]. J Gynecol Oncol 2015
27
33

HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm.
Giuseppina Ruggeri, Elisabetta Bandiera, Laura Zanotti, Silvana Belloli, Antonella Ravaggi, Chiara Romani, Eliana Bignotti, Renata A Tassi, Germana Tognon, Claudio Galli,[...]. Clin Chim Acta 2011
74
12

The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
Karen K L Chan, Chi-An Chen, Joo-Hyun Nam, Kazunori Ochiai, Sarikapan Wilailak, Aw-Tar Choon, Subathra Sabaratnam, Sudarshan Hebbar, Jaganathan Sickan, Beth A Schodin,[...]. Gynecol Oncol 2013
58
15

Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.
Elisabetta Bandiera, Chiara Romani, Claudia Specchia, Laura Zanotti, Claudio Galli, Giuseppina Ruggeri, Germana Tognon, Eliana Bignotti, Renata A Tassi, Franco Odicino,[...]. Cancer Epidemiol Biomarkers Prev 2011
89
10

Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.
Frederick R Ueland, Christopher P Desimone, Leigh G Seamon, Rachel A Miller, Scott Goodrich, Iwona Podzielinski, Lori Sokoll, Alan Smith, John R van Nagell, Zhen Zhang. Obstet Gynecol 2011
137
9

Diagnostic value of HE4 for ovarian cancer: a meta-analysis.
Shuang Yu, Hui-jie Yang, Shu-qin Xie, Yi-Xi Bao. Clin Chem Lab Med 2012
36
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.